Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-04 4:15 pm | N/A 2034-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 346,000 | $0 | 346,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:15 pm | N/A 2034-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 119,000 | $0 | 124,266 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:15 pm | N/A 2034-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Jones Jullian G Chief Business Officer | 79,000 | $0 | 79,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:15 pm | N/A 2034-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 121,000 | $0 | 126,252 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:15 pm | N/A 2034-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel | 109,000 | $0 | 109,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:15 pm | N/A 2034-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer | 60,900 | $0 | 60,900 (Direct) | View |
Ownership | 2023-08-18 4:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer | 0 | $0 | 92,876 (Direct) | View |
| 2023-07-25 Option Award | 2023-07-26 4:10 pm | N/A 2033-07-24 | Monte Rosa Therapeutics Inc. | GLUE | Manning Anthony M. Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:42 pm | N/A 2033-06-13 | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:29 pm | N/A 2033-06-13 | Monte Rosa Therapeutics Inc. | GLUE | Skvarka Jan Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:28 pm | N/A 2033-06-13 | Monte Rosa Therapeutics Inc. | GLUE | Siu Christine Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:28 pm | N/A 2033-06-13 | Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:27 pm | N/A 2033-06-13 | Monte Rosa Therapeutics Inc. | GLUE | Mayweg Alexander Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:26 pm | N/A 2033-06-13 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-03-30 Option Award | 2023-03-31 4:15 pm | N/A 2033-03-29 | Monte Rosa Therapeutics Inc. | GLUE | Skvarka Jan Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 472,000 | $0 | 472,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel | 123,650 | $0 | 123,650 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer | 78,550 | $0 | 78,550 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:30 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Jones Jullian G Chief Business Officer | 77,450 | $0 | 77,450 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:30 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Castle John C. Chief Data Scientist | 78,500 | $0 | 78,500 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:30 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Tamboli Ajim Chief Financial Officer | 129,850 | $0 | 129,850 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:30 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 4:42 pm | N/A 2032-10-02 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 36,000 | $0 | 36,000 (Direct) | View |
| 2022-10-31 Option Award | 2022-11-01 4:30 pm | N/A 2032-10-02 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 36,000 | $0 | 36,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 5:29 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:32 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Siu Christine Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:31 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:30 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Mayweg Alexander Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:30 pm | N/A 2032-06-14 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:49 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Jones Jullian G Chief Business Officer | 73,300 | $0 | 73,300 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:47 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Tamboli Ajim Chief Financial Officer | 111,700 | $0 | 111,700 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:46 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 86,500 | $0 | 86,500 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:46 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Technology Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:43 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel | 70,600 | $0 | 70,600 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:42 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Castle John C. Chief Data Scientist | 53,700 | $0 | 53,700 (Direct) | View |
Ownership | 2022-03-02 6:39 pm | N/A 2031-05-16 | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip General Counsel | 0 | $0 | 116,120 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:32 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 117,450 | $0 | 117,450 (Direct) | View |